{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:56:45Z","timestamp":1790272605770,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejso.2015.06.011","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T19:27:14Z","timestamp":1436988434000},"page":"1529-1539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged \u226566 years"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1298-8231","authenticated-orcid":false,"given":"F.","family":"Abdollah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Sammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Reznor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Klett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.K.","family":"Choueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.-D.","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"59","key":"10.1016\/j.ejso.2015.06.011_bib1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics","volume":"2009","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2015.06.011_bib2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2015.06.011_bib3","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/jnci\/djp262","article-title":"Contemporary risk profile of prostate cancer in the United States","volume":"101","author":"Shao","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2015.06.011_bib4","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.eururo.2010.09.029","article-title":"Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer","volume":"58","author":"Abdollah","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2015.06.011_bib5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1464-410X.1997.d01-6840.x","article-title":"Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group","volume":"79","year":"1997","journal-title":"Br J Urology"},{"key":"10.1016\/j.ejso.2015.06.011_bib6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2015.06.011_bib7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2015.06.011_bib8","first-page":"289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.ejso.2015.06.011_bib9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1470-2045(11)70063-8","article-title":"Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial","volume":"12","author":"Denham","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2015.06.011_bib10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2015.06.011_bib11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/annonc\/mds618","article-title":"Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications","volume":"24","author":"Kuykendal","year":"2013","journal-title":"Ann Oncol Official J Eur Soc Med Oncol\/ESMO"},{"key":"10.1016\/j.ejso.2015.06.011_bib12","series-title":"Medicare: payments for covered outpatient drugs exceed providers costs","first-page":"10","author":"General Accounting Office","year":"2001"},{"issue":"13","key":"10.1016\/j.ejso.2015.06.011_bib13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1200\/JCO.2013.52.5782","article-title":"Effectiveness of primary androgen-deprivation therapy for clinically localized prostate Cancer","volume":"32","author":"Potosky","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.06.011_bib14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jama.300.2.173","article-title":"Survival following primary androgen deprivation therapy among men with localized prostate cancer","volume":"300","author":"Lu-Yao","year":"2008","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.ejso.2015.06.011_bib15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.eururo.2009.03.066","article-title":"The role of primary androgen deprivation therapy in localized prostate cancer","volume":"56","author":"Wong","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2015.06.011_bib16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1464-410X.2006.06416.x","article-title":"The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study","volume":"98","author":"Barry","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ejso.2015.06.011_bib17","first-page":"1436","article-title":"Rising PSA in nonmetastatic prostate cancer","volume":"21","author":"Moul","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2015.06.011_bib18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2015.06.011_bib19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0090-4295(99)00301-5","article-title":"Androgen deprivation therapy for prostate cancer results in significant loss of bone density","volume":"54","author":"Wei","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.ejso.2015.06.011_bib20","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2015.06.011_bib21","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2015.06.011_bib22","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2015.06.011_bib23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2015.06.011_bib24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer","volume":"91","author":"Smith","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2015.06.011_bib25","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1200\/JCO.2008.20.0923","article-title":"Impact of androgen deprivation therapy on cardiovascular disease and diabetes","volume":"27","author":"Alibhai","year":"2009","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"IV","key":"10.1016\/j.ejso.2015.06.011_bib26","first-page":"3","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.ejso.2015.06.011_bib27","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1001\/jama.296.22.2683","article-title":"Survival associated with treatment vs observation of localized prostate cancer in elderly men","volume":"296","author":"Wong","year":"2006","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.ejso.2015.06.011_bib28","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ejso.2015.06.011_bib29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.7326\/0003-4819-159-10-201311190-00005","article-title":"Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies","volume":"159","author":"Cho","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejso.2015.06.011_bib30","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer","volume":"341","author":"Messing","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2015.06.011_bib31","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ijrobp.2011.04.067","article-title":"Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction","volume":"82","author":"Nguyen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2015.06.011_bib32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/jama.2013.8638","article-title":"Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer","volume":"310","author":"Lapi","year":"2013","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.ejso.2015.06.011_bib33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.eururo.2012.01.045","article-title":"Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism","volume":"61","author":"Hu","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2015.06.011_bib34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.eururo.2012.04.035","article-title":"Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?","volume":"64","author":"Keating","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2015.06.011_bib35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.2009.1137","article-title":"Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction","volume":"302","author":"Nanda","year":"2009","journal-title":"JAMA J Am Med Assoc"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315005223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315005223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T19:21:37Z","timestamp":1537471297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798315005223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0748798315005223"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2015.06.011","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged \u226566 years","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2015.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}